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Background and Aims: Malfunctions of enteric neurons are believed to play an
important role in the pathophysiology of irritable bowel syndrome (IBS). Our aim was to
investigate whether neuronal activity in biopsies from IBS patients is altered in comparison
to healthy controls (HC).
Methods: Activity of human submucous neurons in response to electrical nerve
stimulation and local application of nicotine or a mixture of histamine, serotonin, tryptase,
and TNF-α (IBS-cocktail) was recorded in biopsies from 17 HC and 35 IBS patients with
the calcium-sensitive-dye Fluo-4 AM. The concentrations of the mediators resembeled
those found in biopsy supernatants or blood. Neuronal activity in guinea-pig submucous
neurons was studied with the voltage-sensitive-dye di-8-ANEPPS.
Results: Activity in submucous ganglia in response to nicotine or electrical nerve
stimulation was not different between HC and IBS patients (P = 0.097 or P = 0.448).
However, the neuronal response after application of the IBS-cocktail was significantly
decreased (P = 0.039) independent of whether diarrhea (n = 12), constipation (n = 5)
or bloating (n = 5) was the predominant symptom. In agreement with this we found that
responses of submucous ganglia conditioned by overnight incubation with IBS mucosal
biopsy supernatant to spritz application of this supernatant was significantly reduced
(P = 0.019) when compared to incubation with HC supernatant.
Conclusion: We demonstrated for the first time reduced neuronal responses in mucosal
IBS biopsies to an IBS mediator cocktail. While excitability to classical stimuli of enteric
neurons was comparable to HC, the activation by the IBS-cocktail was decreased. This
was very likely due to desensitization to mediators constantly released by mucosal and
immune cells in the gut wall of IBS patients.
Keywords: irritable bowel syndrome, enteric nerve desensitization, immune mediators, colonic biopsy,
submucous plexus, calcium imaging
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INTRODUCTION
The prevalence of irritable bowel syndrome (IBS) is estimated to
be around 10–20% throughout the world. The main symptoms
of this functional disease are abdominal pain, bloating, and
stool irregularities (Longstreth et al., 2006). Based on whether
diarrhea, constipation or a mixture of both prevail, patients may,
according to Rome III criteria, be subgrouped as IBS-D, IBS-C, or
IBS-M, respectively (Drossman, 2006). The German guidelines
define IBS-bloating as another subgroup, in particular if these
patients do not report stool irregularities but merely abdominal
pain (Layer et al., 2011). So far satisfactory treatment is rarely
achieved.
Several mechanisms appeared to be important in the
generation of IBS symptoms including motility disorders, altered
visceral sensitivity and pain processing, increased mucosal
permeability, altered microbiota, and low grade inflammation
(see Corsetti et al., 2014). There is strong evidence that the
immune system (Bashashati et al., 2014) and its interaction
with the enteric nervous system (ENS) is involved in the
pathophysiology of IBS. The human ENS consists of the
myenteric plexus located between the two outer muscle layers
and the submucous plexus with three separate plexuses between
the circular muscle and the epithelial layer. The submucous
plexus controls transport across the mucosa, microcirculation
as well as circular muscle activity (see Schemann and Neunlist,
2004). Immune cells such as mast cells are particularly numerous
in the submucous plexus. The anatomical and functional
interactions between immune cells, in particular mast cells, and
submucous neurons is the basis for neuroimmune interactions in
the lamina propria (see Buhner and Schemann, 2012; Schemann
and Camilleri, 2013). IBS patients show an increased number of
mast cells in close proximity to submucous neurons (Barbara
et al., 2004; Balestra et al., 2012). The mast cell to enteric
nerve signaling is primarily through the release of histamine
and tryptase, which are known to activate neurons of the
submucous plexus (Breunig et al., 2007; Mueller et al., 2011).
Accordingly, a supernatant obtained from stimulated mast cells
had an excitatory effect on guinea pig and human enteric
ganglia (Schemann et al., 2005). Furthermore, brief application
(several 100ms) of mucosal biopsy supernatants of IBS patients
but not of healthy controls activated enteric neurons and this
activation involved histamine and proteases (Buhner et al.,
2009). The relevance of altered neuroimmune interactions in
IBS is supported by the finding that a panel of chemokines
and cytokines as well as antibodies and factors involved in
wound healing and mucosal regeneration were upregulated in
the serum of IBS patients. The role of blood borne factors
was demonstrated by the sensitizing effect of supernatants of
peripheral blood mononuclear cells (PBMC) of IBS-D patients
on mouse colonic afferent nerve endings. This effect was mainly
due to the increased concentration of TNF-α (Hughes et al.,
Abbreviations: IBS, irritable bowel syndrome; HC, healthy controls; ENS, enteric
nervous system; PBMC, peripheral blood mononuclear cells; [Ca2+]i, intracellular
calcium-increase; TNF-α, tumor necrosis factor alpha; PAR, protease-activated
receptor.
2013). Apart from immune cells, there are also enteroendocrine
cells in the epithelium that modulate nerve activity by release
of their mediators. One important mediator is serotonin, which
is enhanced in IBS (Crowell, 2004). Although not significantly
increased in mucosal biopsy supernatants of patients with IBS
(Coates et al., 2004), serotonin contained in mucosal biopsy
supernatants contributes to neuronal activation (Buhner et al.,
2012) as well as to the symptoms of IBS patients (Gershon, 2005).
These and other findings strongly suggest that IBS patients
may experience an altered activation profile of enteric neurons.
So far studies have been using biopsies of IBS patients to
study mediator release, nerve, and mast cell density or receptor
expression (Nasser et al., 2014). Our aim was to directly measure
neuronal activation in tissue samples of the submucous plexus
of IBS patients to study altered neuronal behavior in IBS.
The stimuli used to challenge enteric neurons were: electrical
stimulation of neural synapses, activation of nicotinic receptors
reflecting the action of the most important excitatory transmitter
acetylcholine and a mediator cocktail mimicking an IBS-like
milieu.
MATERIALS AND METHODS
Study Participants and Tissue Samples
We originally recruited 190 healthy volunteers and 106 IBS
patients. We obtained suitable biopsies from 17 healthy
volunteers (58 ± 12 years; 7 female and 10 male) and 35 patients
with IBS (48 ± 13 years; 26 female and 9 male); for details see
Results. All IBS patients were subtyped according to predominant
stool irregularities following the ROME III consensus as IBS-D
(16 patients; 46 ± 14 years; 11 female and 5 male), IBS-C
(8 patients; 51 ± 14 years; 6 female and 2 male), or IBS-M
(5 patients; 47 ± 7 years; 4 female and 1 male). Following
the German guidelines which do not exclusively consider stool
patterns, six additional patients were subtyped as IBS-bloating
with abdominal pain but no stool irregularities (50 ± 11
years; 5 female and 1 male). Details of patients and healthy
volunteers are found in Table 1. As outlined in Table 1 some
patients took medication but all patients had symptoms at the
time of endoscopy. Endoscopies were performed in primary or
secondary care centers for gastroenterology in Munich, Freising,
or Vilsbiburg, respectively. Healthy volunteers were undergoing
routine endoscopy for cancer screening. All volunteers were
asked to fill out the German equivalent of the self-report Rome
III Modular Questionnaire for IBS (Drossman, 2006). Exclusion
criteria for healthy controls were symptoms related to the GI
tract. This was either given if healthy volunteers matched positive
for ROME III criteria or reported one or more of the following
symptoms: (a) abdominal pain for 1 day per month or more (for
women: not related tomenses) (b) hard or lumpy stool more than
25% of the time (c) loose, mushy or watery stool more than 25%
of the time. Exclusion criterion for both healthy controls and IBS
patients was prior surgery of the gastrointestinal tract. All IBS
patients presented themselves to the medical institutions after
experiencing gastrointestinal symptoms. Patients were diagnosed
by experienced gastroenterologists according to Rome III criteria
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TABLE 1 | Characteristics of IBS patients and healthy volunteers.
Clinic Age Gender Medication Diagnosis Clinic Age Gender Diagnosis
Munich 39 f none IBS-Bloating Freising 27 f Healthy Control
Munich 39 f none IBS-Bloating Freising 32 f Healthy Control
Munich 49 m none IBS-Bloating Freising 62 f Healthy Control
Vilsbiburg 62 f none IBS-Bloating Freising 63 f Healthy Control
Vilsbiburg 68 f none IBS-Bloating Freising 47 m Healthy Control
Freising 48 f none IBS-C Freising 56 m Healthy Control
Munich 43 f none IBS-C Freising 59 m Healthy Control
Munich 71 f none IBS-C Freising 60 m Healthy Control
Munich 53 m none IBS-C Freising 64 m Healthy Control
Vilsbiburg 27 f Laxative IBS-C Freising 69 m Healthy Control
Vilsbiburg 40 f none IBS-C Freising 76 m Healthy Control
Vilsbiburg 43 f none IBS-C Munich 58 f Healthy Control
Vilsbiburg 53 f Bisacodyl IBS-C Munich 59 f Healthy Control
Vilsbiburg 71 f none IBS-C Munich 63 f Healthy Control
Munich 39 f none IBS-D Munich 58 m Healthy Control
Munich 42 f none IBS-D Vilsbiburg 58 m Healthy Control
Munich 45 f none IBS-D Vilsbiburg 67 m Healthy Control
Munich 47 f none IBS-D
Munich 54 f none IBS-D
Munich 67 f none IBS-D
Munich 67 f none IBS-D
Munich 31 m none IBS-D
Munich 32 m Loperamid IBS-D
Munich 37 m none IBS-D
Munich 48 m none IBS-D
Munich 56 m none IBS-D
Vilsbiburg 16 f Butylscopolamin IBS-D
Vilsbiburg 23 f none IBS-D
Vilsbiburg 45 f Mebeverin IBS-D
Vilsbiburg 54 m none IBS-D
Munich 41 f none IBS-M
Munich 47 f none IBS-M
Munich 52 f none IBS-M
Vilsbiburg 36 f none IBS-M
Vilsbiburg 57 m Probiotics IBS-M
and the German guidelines (for IBS-bloating). The procedure of
taking biopsies was similar to the method already described by
Cirillo et al. (2013). Four biopsies were taken from the sigmoid
colon with standard biopsy forceps without needle (Ø 2.3mm;
Pauldrach, Garbsen, Germany). After removal all biopsies were
immediately transferred to a sterile glass bottle containing 10ml
of ice-cold, sterile Hepes/Krebs solution (in mmol/l: 135 NaCl, 3
Hepes, 12.2 Glucose, 5.4 KCl, 1 MgCl2.6H2O, 1.25 CaCl2.2H2O,
1.2 NaH2PO4; pH = 7.4) and transported to the laboratory.
The duration of the transport lasted between 20min and 2 h
during which the samples were kept at 4◦C. All procedures were
approved by the ethics committee of the Technische Universität
München (2595/09). Written confirmed consent was obtained
from all participants.
Submucosal tissue from three male guinea-pigs (Dunkin
Hartley, Harlan Winkelmann, Borchen, Germany) was used
for over-night incubation with mucosal biopsy supernatants.
The animals were sacrificed by cervical dislocation and
exsanguination in accordance to German guidelines for animal
welfare and protection (Deutsches Tierschutzgesetz) and
approved by the Bavarian state ethics committee (Regierung
Oberbayern, which serves as the Institutional Care and Use
Committee for the Technische Universität München) according
to §11 Deutsches Tierschutzgesetz under the reference number
32-568. Colonic segments were removed immediately.
Tissue Preparation
Immediately after arrival the human tissue samples were
prepared for the imaging experiments in ice-cold, oxygenated
Krebs solution for dissection (in mmol/l: 117 NaCl, 25 NaHCO3,
11 Glucose, 4.7 KCl, 1.2 MgCl2.6H2O, 2.5 CaCl2.2H2O,
1.2 NaH2PO4; pH = 7.4, 293 mosmol/l). To maintain the
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physiological milieu and to mimic in vivo conditions as closely
as possible, no further dissection was performed and therefore
the mucosa remained a part of the preparation. For the imaging
experiment the whole, undissected biopsy was gently stretched
and pinned flat on a Sylgard-platelet with the submucous
ganglion layer facing upwards. Connective tissue was removed
so that the inner submucous plexus was accessible.
For the over-night incubation of guinea pig submucous plexus
preparations a 5 × 5mm piece of the distal colon was used.
The muscle layers and the mucosa were removed and the
submucous plexus was stretched and pinned flat on a Sylgard-
platelet. After dissection, the Sylgard-platelet with the submucous
plexus preparation was transferred to a petri-dish. Under sterile
conditions an incubation chamber made of Sylgard with an inner
opening of 5×5mmwas mounted on top of the Sylgard-platelet.
We verified in preliminary experiments that the solutions inside
and outside of the chamber were completely separated from each
other (data not shown). Two preparations of submucous plexus
of the same guinea pig were incubated in parallel. Supernatants
were collected as previously published (Barbara et al., 2007). The
preparation was incubated with 100µl of a 1:10 dilution of biopsy
supernatants from either an IBS patient (IBS-D 11, female) or
healthy control (HC 07, female) for 16–18 h at 37◦C with 5%
CO2. To guarantee a moisturized atmosphere and to prevent
evaporation, the petri-dish was filled with 3ml of Krebs solution
that surrounded the incubation chamber.
Imaging Method
The previously described fast imaging technique (Schemann
et al., 2002) was used with small modifications. To facilitate the
recording of neuronal activity in human biopsies with attached
mucosa, all experiments were performed with an upright Zeiss
Examiner D1 microscope with water immersion objective (Plan-
Apochromat 40x/1.0 DIC M27, Zeiss, Oberkochen, Germany).
The same settings were used for experiments with guinea-pig
submucous plexus preparations.
To record neuronal activity in human colonic biopsies
calcium-imaging with 10µmol/l Fluo-4 AM (Invitrogen,
Darmstadt, Germany) was used to monitor intracellular
calcium increase ([Ca2+]i) (Michel et al., 2011). As previously
described, ganglia and their neuronal cell bodies including their
shape were easily detected in the bright field image as well
as during the rise of [Ca2+]i (increased Fluo-4 fluorescence),
respectively (Michel et al., 2011; Mueller et al., 2011). Post-hoc
immunohistochemistry was performed in some preparations
using PGP 9.5 as previously described (Mueller et al., 2011) to
verify identification of submucous neurons. Tissue preparations
mounted on the Sylgard-platelet were incubated for 45min in
Fluo-4 AM containing Krebs buffer and subsequently washed for
20min. The Krebs solution (in mmol/l: 117 NaCl, 20 NaHCO3,
11 Glucose, 4.7 KCl, 1.2 MgCl2.6H2O, 2.5 CaCl2.2H2O, 1.2
NaH2PO4; pH = 7.4; 293 mosmol/l) used for incubation,
washing and perfusion during the experiment contained
500µmol/l Probenecid to prevent dye leakage. Submucous
neurons in IBS and HC biopsies were challenged with brief spritz
application of 100µmol/l nicotine, 60µA electrical stimulation
(20Hz train stimulation) of interganglionic fiber tracts and a
mixture containing 1µmol/l histamine, 1µmol/l serotonin,
10 nmol/l tryptase (Merck KGaA, Darmstadt, Germany), and
150 pg/ml TNF-α (Biomol GmbH, Hamburg, Germany). At
these concentrations the mediators did not evoke any or very
weak responses when applied individually (own unpublished
results). As previously shown, much higher concentrations
were necessary to detect nerve activation by these mediators
(Michel et al., 2005; Breunig et al., 2007; Mueller et al., 2011). The
concentrations of the mediators were calculated following the
mean values measured in IBS supernatants (Buhner et al., 2009)
and PBMC supernatants (Hughes et al., 2013) of IBS patients,
taking into account that with our microejection system there is a
1:10 dilution before a substance reaches the ganglion (Breunig
et al., 2007). The mixture was chosen to mimic some nerve
activating components of a mediator cocktail found in colonic
biopsy supernatants and serum of IBS-patients (Buhner et al.,
2009; Hughes et al., 2013) and will be referred to as IBS-cocktail
further on in this paper. The functional relevance relates to the
higher levels of the mediators in the samples or the finding that
antagonists of the mediators reduced the nerve activation by the
biopsy or PBMC supernatants.
To record neuronal activity from guinea-pig submucous
neurons the voltage-sensitive dye di-8-ANEPPS (20µmol/l; Life
Technologies, Darmstadt, Germany) was used as described
previously (Neunlist et al., 1999). Ganglia of the IBS-conditioned
and the HC-conditioned preparations were challenged with short
term spritz application of 100µmol/l nicotine and the IBS-
supernatant (IBS-D 11) that had been used for the incubation.
All experiments were performed at 37◦C and all reagents were
purchased from Sigma-Aldrich, if not stated otherwise.
Data Analysis and Presentation
Analysis of imaging experiments was performed with Neuroplex
10.1.2. (RedShirtImaging, Decatur, GA, USA). For the calcium-
imaging experiments the maximal intracellular calcium increase
relative to resting light level (1F/F) was determined for each
application. As the staining with Fluo-4 AM does not outline
single cells in the ganglion, it is not possible to directly deduce the
number of neurons per ganglion, the percentage of responding
area in each ganglion was calculated instead. As previously
described, the maximal calcium increase, and the percentage
of responding area per ganglion were multiplied to obtain the
neuroindex, a parameter best reflecting the overall neuronal
activity level (Buhner et al., 2014). Throughout the manuscript
the neuroindex values are presented without units. For the
experiments with di-8-ANEPPS action potentials were counted
per neuron and the number of neurons responding per ganglion
was deduced from the image. The spike frequency was multiplied
with the percentage of responding neurons to again obtain a
neuroindex (Buhner et al., 2014).
All statistics and graphs were performed with Sigma Plot
12.5 (Systat Software Inc., Erkrath, Germany). Data in the figures
are presented as box-and-whisker plots illustrating the median
with 25th and 75th quartiles and 10th and 90th percentiles. For
statistical analysis the Mann-Whitney Rank Sum Test, ANOVA
on ranks with Dunn’s method as post-hoc test, Spearman Rank
Order and Fisher exact test were implemented. To compare
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the age of the study participants, the Student t-test was used
and data are given as mean ± SD. Differences were considered
significantly different when P ≤ 0.05.
RESULTS
Contrary to previous work (Lebouvier et al., 2010) it was
not common that the routine colonic biopsies, as taken in
primary and secondary care centers and as approved by the
ethical committee of our University, contained sufficient viable
submucous ganglia to perform calcium imaging. Originally we
recruited 190 HC and 106 IBS patients for this study. Of the HC
biopsies, 79 and 67 did not contain enough submucous plexus
layer or no viable ganglia, respectively. Of the remaining 44
controls, 27 had to be excluded because seven reported non-
IBS related gut symptoms at the time of endoscopy, 19 did
not provide enough information to include them as healthy
controls and one turned out to be IBS-C. Of the biopsies from
106 IBS patients, 41 and 29 did not contain enough submucous
plexus layer or no viable ganglia, respectively. Of the remaining
36 patients with at least one viable ganglion in one of the
four biopsies, two had to be excluded because the diagnosis
IBS was not according to the guidelines used in this study.
In total 17 confirmed healthy controls and 29 confirmed IBS
patients fulfilling ROME III criteria (Drossman, 2006) as well
as six confirmed IBS patients fulfilling criteria established by
the German Society for Metabolic and Digestive Diseases (Layer
et al., 2011) were eligible to be included. According to the
German guidelines diagnosis of IBS also applies to patients with
bothersome bloating but without stool irregularities. This group
is referred to as IBS-bloating.
We recorded from a sufficient number of ganglia to analyze
responses to electrical stimulation, nicotine, and IBS-cocktail in
biopsies from IBS-C, IBS-D, and IBS-bloating. It was not possible
to record responses to all stimuli in biopsies from IBS-M patients.
Neuronal Activity After Nicotine
Application was Not Altered in Biopsies
from IBS Patients
HC and IBS biopsies were challenged with brief spritz application
of nicotine. Nicotine was chosen as a general neural activator
because most enteric neurons express functional nicotinic
receptors (Schemann et al., 2002). Nicotine evoked an increase
in [Ca2+]I in 97% of ganglia in HC (28 out of 29 ganglia, 17
patients) and in 93% of ganglia in IBS biopsies (53 out of 57
ganglia, 35 patients; P= 0.659). Maximal [Ca2+]I, the percentage
of responding ganglionic area and the neuroindex evoked by
nicotine were not different between HC and IBS ganglia (P =
0.402, P = 0.185, and P = 0.097, respectively). There was also no
difference in the nicotine responsiveness between ganglia from
the four different IBS subgroups ([Ca2+]I: P = 0.698; percentage
responding ganglionic area: P = 0.643; neuroindex: P = 0.580)
(Figure 1).
In the German health system, colon cancer screening is paid
for by the insurance companies starting at the age of 55. This
was the main age group recruited for the healthy control cohort.
This meant that our healthy participants were slightly yet still
significantly older than the IBS patients (p = 0.014). It is
therefore important however to stress that the nicotine evoked
neuroindex was independent of age (P = 0.302; correlation
coefficient r: −0.262). There was also a significant difference
for the ratio of men and women in both groups (P = 0.032).
However, there was no difference between the nicotine evoked
neuroindex between male and female subjects (P = 0.438).
We were concerned that IBS biopsies may be more sensitive
to damage than those from HC. Evidence for this would be that
nicotine activated a smaller ganglionic area. This was not the
case as the absolute ganglionic area responding to nicotine was
1500µm2 in IBS and 2000µm2 in HC ganglia (P = 0.76).
Responses to Electrical Stimulation of
Interganglionic Fiber Tracts was Not
Altered in Biopsies from IBS Patients
Electrical stimulation of interganglionic fiber tracts in HC and
IBS biopsies evoked activation in a comparable proportion of
ganglia (61% in HC and 62% in IBS, P = 1; n = 14 patients/21
ganglia and 20 patients/27 ganglia, respectively). The neuronal
activation was not significantly different between the two groups
([Ca2+]I: P = 0.685; percentage responding ganglionic area: P =
0.514; neuroindex: P = 0.448) (Figure 2).
Ganglia of IBS Patients Responded Less to
the IBS-Cocktail Compared to Healthy
Controls
The IBS-cocktail containing serotonin, histamine, tryptase, and
TNF-α evoked a [Ca2+]I increase in 53% and 30% of ganglia in
biopsies from HC (n = 12 patients/17 ganglia) and IBS (n = 24
patients/33 ganglia), respectively. There was no difference in the
proportion of responsive ganglia (P = 0.137). The neuroindex
in response to application of the IBS-cocktail was significantly
lower in submucous ganglia from IBS biopsies compared to
HC (P = 0.039). This was due to a lower median increase in
[Ca2+]I (P = 0.065) and a decreased responding ganglionic area
(P = 0.055). The smaller increase in [Ca2+]I (P = 0.909), the
reduced percentage of responding ganglionic area (P = 0.962)
and the lower neuroindex (P = 0.980) were comparable among
IBS subgroups. The responding cells were neurons because all
exhibited an immediate response to nicotine and/or were PGP 9.5
positive (not always tested, see also Figure 1). In addition, the cell
morphology that was revealed during the rise in [Ca2+]I signal
clearly distinguished small glia cells from large neurons (Mueller
et al., 2011). Responses in IBS-M biopsies were not tested because
successful recording was only possible in two patients (Figure 3).
We found a significant correlation between the age of an IBS
patient and the neuroindex evoked by the IBS-cocktail (P =
0.006, r: 0.448) suggesting that younger patients responded less to
the IBS-cocktail. This was not the case for young healthy controls.
We have no explanation for this observation in particular since
it was independent of patient gender, IBS subtype or the clinic
providing the biopsies, and there was no correlation between
the nicotine evoked neuroindex and patient age (P = 0.721,
r:−0.062).
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FIGURE 1 | Neuronal responses to the spritz application of 100µmol/l nicotine in human submucous ganglia obtained from IBS and HC biopsies. (A)
Image of a Fluo-4 AM labeled ganglion before nicotine application taken with the low resolution CCD camera. (B) Image 2.5 s after nicotine application showing a
peak response in three large diameter cells marked by arrows. (C) The same ganglion after PGP 9.5 staining revealed that the three responding cells were neurons
(image taken with a high resolution camera of the fluorescent microscope). (D) Trace of the three neurons reflect the intracellular calcium increase in response to the
application of nicotine (colored traces respond to colored arrows in A–C). (E) Nicotine evoked responses did not differ between HC and IBS ganglia. The increase in
the neuroindex was comparable. There were also no differences among IBS subgroups.
Over-Night Conditioning of Guinea-Pig
Submucous Plexus Preparations Caused
Desensitization to IBS Mucosal Biopsy
Supernatant
The reduced response to the mediator cocktail in IBS biopsies
contrasted with the excitatory action of brief application of
IBS mucosal biopsy supernatants which contained the most
relevant nerve activating substances (Buhner et al., 2009).
Repeated applications of the supernatants by brief microejection
(400ms) every 20min resulted in reproducible responses in
human and guinea-pig enteric neurons (Buhner et al., 2009).
We hypothesized that the reduced sensitivity to the IBS-
cocktail in IBS-biopsies was the result of long term exposure
of neurons and desensitization to the mediators. To test this
idea we conditioned guinea pig submucous plexus preparations
by overnight incubation with mucosal biopsy supernatants from
an IBS patient or a healthy control. The application of nicotine
evoked action potential discharge in 100% of the ganglia (n =
8) conditioned with the HC supernatant and 100% of ganglia
(n = 7) conditioned with the IBS supernatant. We only analyzed
those ganglia that responded at all to IBS supernatant in order to
reveal gradual changes in the responsiveness betweenHC and IBS
supernatant conditioned tissues. The nicotine evoked neuroindex
was comparable (P = 0.397), as were the spike frequency (P =
0.536) and the percentage of responding neurons per ganglion
(P = 0.463). We then challenged the ganglia with the same IBS
supernatant that had been used for conditioning the tissue. The
neuroindex evoked by the IBS supernatant in the tissue that had
been preincubated with this supernatant was significantly smaller
compared to the one in HC preincubated ganglia (P = 0.019,
Figure 4). This was due to a lower number of spikes (1.8 vs.
4.6Hz) and to less neurons responding (18 vs. 64% responding
neurons).
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FIGURE 2 | Neuronal response to electrical stimulation of interganglionic fiber tracts. (A) Submucous ganglion stained with the calcium-sensitive dye Fluo-4
AM. The trace reflects [Ca2+ ]i transients in response to electrical stimulation in the cell marked by the white arrow. (B) Electrical stimulation evoked comparable
increases in the neuroindex in IBS and HC biopsies as well as between IBS subgroups.
FIGURE 3 | Neuronal response to the spritz application of an IBS-cocktail on submucous ganglia in IBS and HC biopsies. (A) Submucous ganglion
stained with the calcium-sensitive dye Fluo-4 AM. The trace reflects [Ca2+ ]i increase in response to application of the IBS-cocktail in the cell marked by the white
arrow. (B) The IBS-cocktail evoked significantly smaller neuronal activation in ganglia from IBS biopsies as indicated by the reduced neuroindex (*p < 0.05). There was
no significant difference between the subtypes IBS-D, IBS-C, and IBS-bloating.
DISCUSSION
With this study we have shown for the first time altered neuronal
activity in the submucous plexus of IBS patients in response to
a combination of mucosal and immune mediators (referred to
as IBS-cocktail). Importantly, responses to nicotine and electrical
nerve stimulation did not differ between IBS and control biopsies.
This is another indication that IBS is not a mere psychosomatic
disease but associated with defined organic disorders.
The study revealed a number of novel and also unexpected
findings which contrast some current concepts on the
pathophysiology of IBS. We and others have shown that
short term application of mucosal biopsy supernatants from
IBS patients significantly enhanced spike discharge in enteric
neurons (Buhner et al., 2009, 2012) and visceral afferents
(Hughes et al., 2013) as well as [Ca2+]i transients in dorsal root
ganglion neurons (Cenac et al., 2007). This led to the hypothesis
that nerves in the gut wall of IBS patients are constantly
activated and may be even over excitable. It was therefore
surprising to find that the response to electrical stimulation
of interganglionic fiber tracts or nicotine application did not
reveal such enhanced neuronal excitability in IBS biopsies. Both
stimuli are well-suited to generally test for neuronal excitability
because electrical stimulation enhances synaptic release and
nicotine activates the majority of enteric neurons directly via
postsynaptic nicotinic receptors. Even more surprising was
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FIGURE 4 | Overnight incubation with an IBS biopsy supernatant but not with a HC biopsy supernatant desensitized the neurons to application of IBS
supernatant. (A) Representative traces to spritz application of nicotine or IBS supernatant in HC and IBS preincubated tissues. (B) Nicotine evoked responses,
expressed as neuroindex, were comparable in tissues conditioned by IBS or HC supernatants. (C) Application of the IBS supernatant which had been used to
condition the tissues (= IBS conditioned) evoked a significantly smaller neuronal activity in IBS compared to HC-conditioned tissue as revealed by a reduced
neuroindex.
that the IBS-cocktail that was chosen to mimic enhanced levels
of serotonin, histamine, tryptase, and TNF-α found in IBS
biopsy supernatants or serum caused a significantly lower neural
activation in IBS compared to HC biopsies. Due to the limit
in material availability and the fact that the artificial cocktail
was much better defined we did not use biopsy supernatants
as a stimulus. Although the mediator concentrations vary
between biopsy supernatants they were on average higher in
IBS compared to healthy controls (Buhner et al., 2009). The
concentrations of serotonin, histamine, tryptase, and TNFα were
therefore deduced from the concentrations measured in IBS
biopsy supernatants (Buhner et al., 2009) or PBMC supernatants
(Hughes et al., 2013). There is no reason to believe that lower or
supramaximal concentrations may lead to different findings and
there is a more likely explanation for the reduced response of the
IBS-cocktail in IBS biopsies. We suggest that submucous neurons
of IBS patients are constantly exposed to a plethora of mediators
among which are those used as a stimulus in our study. In some
studies, brief exposure of nerves to such a milieu, mimicked
by the IBS biopsy supernatants, immediately, and directly
activated them in preparations from healthy human controls or
in animal tissue (Barbara et al., 2007; Buhner et al., 2009, 2012,
2014; Hughes et al., 2013). This activation was also observed
after individual application of serotonin (Michel et al., 2005),
histamine (Breunig et al., 2007), tryptase (Mueller et al., 2011)
or TNF-α (O’Malley et al., 2011) to enteric neurons, though
much higher concentrations were used in these experiments.
The same studies also reported strong receptor desensitization
to repeated and/or long term exposure to each of the substances
when applied at high concentrations. Apparently, this is what
happened in the IBS biopsies. This notion is supported in
our study since overnight incubation of submucous plexus
preparations with IBS biopsy supernatant caused a substantially
decreased responsiveness to the application of the supernatant
when compared to its response when incubated with HC biopsy
supernatants. For this particular experiment we used the biopsy
supernatants in order to mimic as closely as possible the milieu
enteric neurons would be exposed to in a healthy or IBS gut.
We did not use the IBS-cocktail because we wanted to find out
whether we were able to mimic the situation in patients and
indeed find desensitization to the IBS but not HC supernatants.
The desensitization may be a physiological response to protect
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nerves from over-excitation by the enhanced release of epithelial
and immune mediators in IBS.
Although the above is a plausible interpretation of our
findings we have to acknowledge certain limitations of our
study. We cannot fully rule out that enteric neurons in biopsies
undergo some plastic changes during either the pretreatment of
the patients before endoscopy, the handling of the biopsies, the
transport, or the tissue preparation for [Ca2+]I recording. We
were very cautious to keep these influences to a minimum. For
example, we used the fastest possible way to transport the biopsies
to the laboratory ranging from 20min to 2 h. In addition we
did not perform further dissection of the biopsies which might
influence excitability by stressing the tissue. Most importantly
however, any particular influence would have affected the IBS
biopsies to the same degree as the HC biopsies since all
were handled similarly. Since we have seen clear differences
we may safely conclude that the reduced action of the IBS-
cocktail was indeed a genuine reduced responsiveness of enteric
neurons in IBS biopsies. Although there is no clinical or
experimental evidence, we cannot rule out that IBS biopsies
may be more sensitive to the employed experimental procedures
and therefore may release more mediators which result in a
more pronounced desensitization. In addition, we can only
conclude that the desensitization was present at the time of
endoscopy. We assume that there is nerve activation at some
state of the disease as there would not be any desensitization
without prior receptor activation. In this context it is important
to again emphasize that all patients had symptoms at the time
of endoscopy independent of whether they took medications or
not.
Our method to maintain the mucosal milieu of the biopsies by
leaving the mucosa attached to the submucous tissue and thereby
preventing a re-adaption to the altered conditions during the
incubation period and the duration of the experiment, has never
been used before. The method proved feasible and the mucosal
cells underneath the submucous plexus did not affect the readout
of the calcium imaging. The fact that the spritz application by
microejection is a very local stimulus contributed to the fact that
the mucosa did not disturb the measurements at all as we found
no evidence that the applied substances reached the epithelial
cells underneath the plexus.
The reduced responsiveness to the IBS-cocktail was evident
in all subgroups of IBS patients independent of whether they
had diarrhea, constipation, or bloating. This agrees with our
previous finding that IBS biopsy supernatants activated enteric
neurons through serotonin, histamine, and protease receptors
independent of the prevalence of particular symptoms (Buhner
et al., 2012). It was therefore expected to see a decrease of
responsiveness in all IBS subgroups. At first sight it seems
strange that an IBS-cocktail evokes a smaller neuronal response
in patients who experience abdominal pain. However, this is
not unexpected because visceral hypersensitivity in IBS patients
is linked to activation of nociceptive pathways involving dorsal
root ganglion neurons rather than enteric neurons which do
not project outside the gut and therefore don’t transmit pain
signals (Buhner et al., 2014). All our patients experienced
abdominal pain but we don’t know how many actually show
visceral hypersensitivity. An evaluation of visceral sensitivity by
barostat distension is not possible in a primary or secondary care
setting.
Nicotine and electrical stimulation evoked very similar
responses in HC and IBS biopsies. This finding suggested that
there is no general desensitization but also no sensitization of
enteric neurons.
One study demonstrated a sensitizing effect of long term
application of mucosal biopsy supernatants from IBS-D but
not from IBS-C patients on cultured dorsal root ganglion
neurons (Valdez-Morales et al., 2013). The cell bodies of these
neurons are not in close proximity to the mucosal layer and
might therefore respond differently to this mediator milieu. In
addition, the sensitization was observed as a change in basic
electrophysiological properties such as rheobase (just threshold
for spike discharge) and the number of action potentials at
twice the rheobase. It has not been studied how DRG neurons
respond to the supernatant that has been used for the overnight
incubation. The enhanced sensitization in nociceptive DRG
neurons certainly agrees with the clinical manifestation of pain.
We have previously reported that the nerve activating potential
of muscosal biopsy supernatants was closely related to visceral
sensitivity but not at all to stool irregularities (Buhner et al.,
2014).
Desensitization was particularly strong for proteases as
protease-activated receptor (PAR) activation can only be
triggered once for every receptor. After the ligand is cleaved
by the protease and bound to the specific site of the receptor,
it internalizes and has to be recycled by the cell to become
active again (Déry et al., 1998). In IBS patients, not only is
the concentration of tissue proteases elevated, but also the
activity of fecal proteases (Tooth et al., 2014). These proteolytic
activities seem to be present at all time in the gut. Our data
now suggest, that this abundance of activating substances leads
to a desensitization of submucous ganglia of IBS patients and
makes them less responsive to mediators released by immune
and mucosal cells while the interneuronal signaling by the main
transmitter acetylcholine is perfectly maintained.
In this study we included bloating predominant IBS patients
additionally to the subgroups described by the ROME III criteria,
which are characterized by their predominant stool consistency.
Bloating as well as abdominal pain (Manning et al., 1978)
are major symptoms for IBS and therefore should not be left
unstudied. We did not find any differences in neuronal activation
between IBS-D, IBS-C, IBS-M, and IBS-bloating patients for the
stimulus nicotine. For the application of the IBS-cocktail, the
number of IBS-C, and IBS-bloating might have been too low
to draw a final conclusion. There was, however, no significant
difference between the three groups, as they all showed a reduced
response to the IBS-cocktail.
Although the present study showed a reduced response to the
mediator cocktail, our finding does not preclude sensitization to
other transmitters or non-neuronal mediators in IBS biopsies.
Further studies will be necessary to investigate the clinical impact
and consequences of the desensitization of submucous ganglia of
IBS patients to mediators released by immune and mucosal cells
for IBS treatment.
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